1 min read

Federal Court Final Ruling on FDA Regulation of LDTs

Federal Court Final Ruling on FDA Regulation of LDTs

Regarding the ongoing lawsuit challenging the U.S. Food and Drug Administration (FDA) regulation of laboratory-developed tests (LDTs) as medical devices, Judge Sean D. Jordan of the United States District Court, Eastern District of Texas ruled the FDA does not have the legal authority to regulate lab-developed tests. This ruling was signed on March 31, 2025.

The context of the case was that the American Clinical Laboratory Association (ACLA) v. U.S. Food and Drug Administration (FDA) challenged the FDA’s authority to regulate laboratory-developed test (LDTs), tests developed and performed within a single laboratory, under the same framework as medical devices. Historically, LDTs have been regulated under the Clinical Laboratory Improvement Amendments (CLIA), overseen by the Centers for Medicare & Medicaid Services (CMS), rather than the FDA. The ACLA argues that the FDA lacks statutory authority to regulate LDTs as medical devices, while the FDA has pushed for increased oversight, citing patient safety concerns.

The conclusion that LDT services are not “devices” under § 321(h) was confirmed and that “unlike physical products, professional services are not ‘manufactured.’” In summary, the Fifth Circuit has made clear that district courts should generally “nullify and revoke” illegal agency action.

Read ACLA’s full lawsuit.

Read the Final Judgment.

 

PATIENT AI Act Discussion Draft, AMA Issue Brief for Clinical AI Liability Released

PATIENT AI Act Discussion Draft, AMA Issue Brief for Clinical AI Liability Released

Accountability and reimbursement for artificial intelligence (AI)-based technologies were highlighted topics of discussion last week.

Read More
TELCOR Promotions - November 2026

TELCOR Promotions - November 2026

Lincoln, NE – November 2026 TELCOR is proud to announce the promotion of Stephanie Gonnerman to Senior Analyst, Revenue Cycle Management (RCM).

Read More
Recently Released CLFS Data Reveal Large Differences in Test Volume by Laboratory Setting

Recently Released CLFS Data Reveal Large Differences in Test Volume by Laboratory Setting

The Centers for Medicare and Medicaid Services (CMS) released a report on Oct. 20 detailing significant differences in the share of reported test...

Read More